跳转至内容
Merck
CN

H3167

盐酸羟基安非他酮

≥98% (HPLC), DAT and NET inhibitor, powder

别名:

盐酸安非他酮吗啉代杂质, GW 353162, SS-羟基安非他酮盐酸盐, 盐酸拉达法辛, (+)-(2S,3S)-2-(3-氯苯基)-3,5,5-三甲基-2-吗啉代盐酸盐, (2S,3S)-2-(3-氯苯基)-3,5,5-三甲基-2-吗啉代盐酸盐

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C13H18ClNO2 · HCl
化学文摘社编号:
分子量:
292.20
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
Storage condition:
desiccated
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

盐酸羟基安非他酮, ≥98% (HPLC)

Quality Level

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to tan

solubility

DMSO: ≥12 mg/mL

storage temp.

−20°C

SMILES string

Cl.C[C@@H]1NC(C)(C)CO[C@@]1(O)c2cccc(Cl)c2

InChI

1S/C13H18ClNO2.ClH/c1-9-13(16,17-8-12(2,3)15-9)10-5-4-6-11(14)7-10;/h4-7,9,15-16H,8H2,1-3H3;1H/t9-,13+;/m0./s1

InChI key

ORXTVTDGPVINDN-BTJVGWIPSA-N

General description

(2S,3S)-羟基安非他酮是安非他酮的主要代谢产物。

Biochem/physiol Actions

(2S,3S)-羟基安非他酮是多巴胺转运蛋白(DAT)和去甲肾上腺素转运蛋白(NET)转运蛋白抑制剂和烟碱型乙酰胆碱受体(nAChR)家族调节剂。 据报道,羟基安非他酮有助于抗抑郁和戒烟。(2S,3S)和(2R,3R)代谢产物均可逆转尼古丁依赖性小鼠的情感和躯体戒断症状,但(2S,3S)-羟基安非他酮更有效。(2S,3S)-羟基安非他酮可显著降低小鼠的尼古丁奖赏效应。

Features and Benefits

该化合物收录于 受体分类和信号转导手册的《生物胺转运体 》页面。想要浏览手册的其他页面, 请单击此处


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Yating Deng et al.
Drug metabolism and pharmacokinetics, 28(4), 339-344 (2013-02-20)
Gentiopicroside (GE), a naturally occurring iridoid glycoside, has been developed into a Novel Traditional Chinese Drug named gentiopicroside injection, and it was approved for the treatment of acute jaundice and chronic active hepatitis by SFDA. However, the inhibitory and inducible
Matthew L Banks et al.
Behavioural pharmacology, 27(2-3 Spec Issue), 196-203 (2016-02-18)
The dopamine transporter (DAT) inhibitor and nicotinic acetylcholine (nACh) receptor antagonist bupropion is being investigated as a candidate 'agonist' medication for methamphetamine addiction. In addition to its complex pharmacology, bupropion also has two distinct pharmacologically active metabolites. However, the mechanism
E Malcolm et al.
Psychopharmacology, 232(15), 2763-2771 (2015-03-13)
Preclinical studies with bupropion in rodent models of nicotine dependence have generated equivocal findings with regard to translating the clinical efficacy of the antidepressant as a smoking cessation agent. Given that rats are poor metabolizers of bupropion, the present experiments



全球贸易项目编号

货号GTIN
H3167-5MG04061832082448
H3167-25MG04061832082431